Corestreet Logo

Enliven Therapeutics Inc. (ELVN) Insider Trading

Total insider buys:
  • $0.00
Total insider sells:
  • $55,318,056.63
Most recent insider trade:
  • Nov. 27, 2024
Most active insider trader:
  • Benjamin Hohl
Trader NameDateTitleAmountPriceTypeTotal Value
Nov. 27, 2024CFO5,250$24.89Sell$130,672.50
Oct. 28, 2024CFO6,250$28.56Sell$178,500.00
Oct. 18, 2024CFO814$30.00Sell$24,420.00
Oct. 18, 2024Insider847$30.00Sell$25,410.00
Oct. 18, 2024Director817$30.00Sell$24,510.00
Oct. 18, 2024CEO924$30.00Sell$27,720.00
Oct. 18, 2024COO716$30.00Sell$21,480.00
Oct. 15, 2024Director1,270$27.67Sell$35,140.90
Oct. 9, 2024Insider37,878$28.16Sell$1,066,644.48
Oct. 9, 2024CEO16,710$28.15Sell$470,386.50
Oct. 8, 2024Director10,420$28.17Sell$293,531.40
Oct. 7, 2024CFO1,270$27.51Sell$34,937.70
Oct. 7, 2024CEO2,730$27.50Sell$75,075.00
Oct. 7, 2024Insider2,707$27.61Sell$74,740.27
Oct. 4, 2024Insider7,522$27.51Sell$206,930.22
Oct. 4, 2024Director2,825$27.51Sell$77,715.75
Oct. 4, 2024CEO12,206$27.51Sell$335,787.06
Oct. 4, 2024CFO10,218$27.51Sell$281,097.18
Oct. 1, 2024Director518$27.54Sell$14,265.72
Oct. 1, 2024Insider527$27.54Sell$14,513.58
Oct. 1, 2024CEO526$27.54Sell$14,486.04
Sept. 30, 2024CFO2,000$25.33Sell$50,660.00
Sept. 27, 2024CFO4,250$24.27Sell$103,147.50
Aug. 29, 2024Insider12,000$22.49Sell$269,880.00
Aug. 27, 2024CFO4,250$22.54Sell$95,795.00
Aug. 26, 2024CEO12,000$22.89Sell$274,680.00
Aug. 15, 2024Director1,270$23.25Sell$29,527.50
July 31, 2024Insider3,099$27.56Sell$85,408.44
July 31, 2024Director1,702$27.51Sell$46,822.02
July 31, 2024CEO2,270$27.56Sell$62,561.20
July 31, 2024CFO991$27.53Sell$27,282.23
July 29, 2024CFO5,250$26.68Sell$140,070.00
July 29, 2024Insider12,000$26.70Sell$320,400.00
July 25, 2024CEO12,000$24.92Sell$299,040.00
July 15, 2024Director1,270$24.80Sell$31,496.00
July 15, 2024COO30,978$25.05Sell$775,998.90
July 12, 2024CFO3,000$25.07Sell$75,210.00
July 12, 2024COO17,475$25.07Sell$438,098.25
June 27, 2024CFO4,250$22.57Sell$95,922.50
June 25, 2024CEO12,000$21.66Sell$259,920.00
June 6, 2024COO1,133$20.06Sell$22,727.98
May 28, 2024CEO12,000$23.18Sell$278,160.00
May 28, 2024CFO4,250$23.18Sell$98,515.00
May 16, 2024Director1,033,300$22.14Sell$22,877,262.00
May 14, 2024COO1,107$25.00Sell$27,675.00
May 9, 2024COO260$25.06Sell$6,515.60
May 6, 2024COO4,875$22.72Sell$110,760.00
May 3, 2024CFO1,000$22.50Sell$22,500.00
April 29, 2024CFO3,250$16.97Sell$55,152.50
April 29, 2024insider12,000$17.92Sell$215,040.00
First«1 of 2»Last

  • Insiders are selling Enliven Therapeutics Inc. stock.

  • The insider traders at Enliven Therapeutics Inc. are: Benjamin Hohl, Samuel Kintz, Anish Patel, Richard A Heyman, Joseph P. Lyssikatos, Joseph P Lyssikatos, Rahul D Ballal, 5Am Partners Vi, Llc, and Rishi Gupta

  • The most active insider trader at Enliven Therapeutics Inc. is Benjamin Hohl with 22 trades.

  • Rishi Gupta has sold the most Enliven Therapeutics Inc. stock with a total value of $45,754,524.00.

  • The most recent insider trade for Enliven Therapeutics Inc. was on Nov. 27, 2024.

  • The single biggest insider sell for Enliven Therapeutics Inc. was from Rishi Gupta with a total value of $22,877,262.00 on May 16, 2024.